102 related articles for article (PubMed ID: 19766715)
1. High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy.
Eriksson SE; Prast-Nielsen S; Flaberg E; Szekely L; Arnér ES
Free Radic Biol Med; 2009 Dec; 47(11):1661-71. PubMed ID: 19766715
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of thioredoxin reductase 1 by porphyrins and other small molecules identified by a high-throughput screening assay.
Prast-Nielsen S; Dexheimer TS; Schultz L; Stafford WC; Cheng Q; Xu J; Jadhav A; Arnér ES; Simeonov A
Free Radic Biol Med; 2011 May; 50(9):1114-23. PubMed ID: 21262347
[TBL] [Abstract][Full Text] [Related]
3. Combination of TrxR1 inhibitor and lenvatinib triggers ROS-dependent cell death in human lung cancer cells.
Zheng P; Xia Y; Shen X; Lu H; Chen Y; Xu C; Qiu C; Zhang Y; Zou P; Cui R; Huang X
Int J Biol Sci; 2024; 20(1):249-264. PubMed ID: 38164168
[TBL] [Abstract][Full Text] [Related]
4. APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase.
Peng X; Zhang MQ; Conserva F; Hosny G; Selivanova G; Bykov VJ; Arnér ES; Wiman KG
Cell Death Dis; 2013 Oct; 4(10):e881. PubMed ID: 24157875
[TBL] [Abstract][Full Text] [Related]
5. Synergistic targeting of TrxR1 and ATM/AKT pathway in human colon cancer cells.
Shen X; Xia Y; Lu H; Zheng P; Wang J; Chen Y; Xu C; Qiu C; Zhang Y; Xiao Z; Zou P; Cui R; Ni D
Biomed Pharmacother; 2024 May; 174():116507. PubMed ID: 38565059
[TBL] [Abstract][Full Text] [Related]
6. Jolkinolide B synergistically potentiates the antitumor activity of GPX4 inhibitors via inhibiting TrxR1 in cisplatin-resistant bladder cancer cells.
Sang J; Liu CK; Liu J; Luo GC; Zheng WJ; Bai Y; Jiang DY; Pu JN; An S; Xu TR
Biochem Pharmacol; 2024 May; 223():116194. PubMed ID: 38583812
[TBL] [Abstract][Full Text] [Related]
7. [Construction and identification of a HEK293 cell line with stable TrxR1 overexpression].
Lü X; Zhou Z; Zhu L; Zhou J; Huang H; Zhang C; Liu X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):554-560. PubMed ID: 35527491
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the effects of thiazole compounds on thioredoxin reductase 1 (TrxR1), glutathione S-transferase (GST), and glutathione reductase (GR) targeted human brain glioblastoma cancer (U-87 MG).
Korkmaz IN
Biotechnol Appl Biochem; 2024 Apr; ():. PubMed ID: 38682343
[TBL] [Abstract][Full Text] [Related]
9. Inducing ubiquitination and degradation of TrxR1 protein by LW-216 promotes apoptosis in non-small cell lung cancer via triggering ROS production.
Wang R; Zhong L; Wang T; Sun T; Yang J; Liu X; Wu Y; Guo Q; Gao Y; Zhao K
Neoplasia; 2024 May; 53():101004. PubMed ID: 38733769
[TBL] [Abstract][Full Text] [Related]
10. Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells.
Günaydın Ş; Sulukoğlu EK; Kalın ŞN; Altay A; Budak H
J Appl Toxicol; 2023 Nov; 43(11):1676-1685. PubMed ID: 37329199
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, and Bioactivity Evaluations of 3-Methylenechroman-2-one Derivatives as Thioredoxin Reductase (TrxR) Inhibitors.
Nikitjuka A; Ozola M; Krims-Davis K; Žalubovskis R
ChemMedChem; 2024 Feb; 19(3):e202300504. PubMed ID: 38063319
[TBL] [Abstract][Full Text] [Related]
12. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose.
Du Y; Zhang H; Lu J; Holmgren A
J Biol Chem; 2012 Nov; 287(45):38210-9. PubMed ID: 22977247
[TBL] [Abstract][Full Text] [Related]
13. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
Prast-Nielsen S; Cebula M; Pader I; Arnér ES
Free Radic Biol Med; 2010 Dec; 49(11):1765-78. PubMed ID: 20851179
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin reductase inhibition elicits Nrf2-mediated responses in Clara cells: implications for oxidant-induced lung injury.
Locy ML; Rogers LK; Prigge JR; Schmidt EE; Arnér ES; Tipple TE
Antioxid Redox Signal; 2012 Nov; 17(10):1407-16. PubMed ID: 22607006
[TBL] [Abstract][Full Text] [Related]
15. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy.
Stafford WC; Peng X; Olofsson MH; Zhang X; Luci DK; Lu L; Cheng Q; Trésaugues L; Dexheimer TS; Coussens NP; Augsten M; Ahlzén HM; Orwar O; Östman A; Stone-Elander S; Maloney DJ; Jadhav A; Simeonov A; Linder S; Arnér ESJ
Sci Transl Med; 2018 Feb; 10(428):. PubMed ID: 29444979
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the human thioredoxin gene promoter and its key substrates: a study of functional and putative regulatory elements.
Hawkes HJ; Karlenius TC; Tonissen KF
Biochim Biophys Acta; 2014 Jan; 1840(1):303-14. PubMed ID: 24041992
[TBL] [Abstract][Full Text] [Related]
17. Glutathione peroxidases.
Brigelius-Flohé R; Maiorino M
Biochim Biophys Acta; 2013 May; 1830(5):3289-303. PubMed ID: 23201771
[TBL] [Abstract][Full Text] [Related]
18. TrxR1 as a potent regulator of the Nrf2-Keap1 response system.
Cebula M; Schmidt EE; Arnér ES
Antioxid Redox Signal; 2015 Oct; 23(10):823-53. PubMed ID: 26058897
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma.
Raninga PV; Di Trapani G; Vuckovic S; Bhatia M; Tonissen KF
Oncotarget; 2015 Jun; 6(17):15410-24. PubMed ID: 25945832
[TBL] [Abstract][Full Text] [Related]
20. Dietary methionine can sustain cytosolic redox homeostasis in the mouse liver.
Eriksson S; Prigge JR; Talago EA; Arnér ES; Schmidt EE
Nat Commun; 2015 Mar; 6():6479. PubMed ID: 25790857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
